Article
MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.
Blood advances - 24 Feb 2026
Boertjes Emma L, Grob Tim, Al Hinai Adil, Beverloo Berna H B, Versluis Jurjen, Kavelaars François G, Rijken Melissa, Compagne Kyra G, Erpelinck Claudia A J, Sanders Mathijs A, Stoetman Elodie C G, Hanekamp Diana, Gradowska Patrycja L, Ossenkoppele Gert J, Biemond Bart J, Manz Markus G, Pabst Thomas, Jongen-Lavrencic Mojca, Löwenberg Bob, Valk Peter J M
Abstract excerpt
ABSTRACT: Acute myeloid leukemia (AML) is driven by diverse genetic abnormalities. We investigated clinical and molecular differences between clinically defined secondary AML following antecedent MDS, molecularly defined secondary type AML (st-AML), molecularly defined MDS/AML (st-MDS/AML; 10%-19% blasts) and other newly diagnosed AML (de novo AML). We also examined the prognostic value of molecular measurable...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
